New dissolving heart implant could ease migraines without metal side effects

NCT ID NCT06203873

Recruiting now Symptom relief Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if a new biodegradable heart implant can reduce migraine days better than a standard metal implant in people with a small hole in the heart (PFO). The new implant is designed to dissolve over time, potentially avoiding long-term complications like metal allergies. Researchers will track how much migraine days drop per month over a year in 400 adults aged 18-65.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

migraine disorder patent foramen ovale

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MIGRAINE MIGRAINE HEADACHE MIGRAINE HEADACHE, WITH OR WITHOUT AURA PFO - PATENT FORAMEN OVALE

Contacts and locations

Locations

Fuwai Hospital
NOT_YET_RECRUITING

Beijing, Beijing Municipality, 100037, China
Fuwai Hospital
RECRUITING

Beijing, Beijing Municipality, 100037, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.